Cited by 474MicroRNA in disease regulationAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Alteration of the microRNA network during the progression of Alzheimer's disease

Open access
Lau, Pierre, Bossers, Koen, Janky, Rekin's, Salta, Evgenia, Frigerio, Carlo Sala, Barbash, Shahar, Rothman, Roy, Sierksma, Annerieke S. R. +10 more·2013·EMBO Molecular Medicine

Abstract

An overview of miRNAs altered in Alzheimer's disease (AD) was established by profiling the hippocampus of a cohort of 41 late‐onset AD (LOAD) patients and 23 controls, showing deregulation of 35 miRNAs. Profiling of miRNAs in the prefrontal cortex of a second independent cohort of 49 patients grouped by Braak stages revealed 41 deregulated miRNAs. We focused on miR‐132‐3p which is strongly altered in both brain areas. Downregulation of this miRNA occurs already at Braak stages III and IV, before loss of neuron‐specific miRNAs. Next‐generation sequencing confirmed a strong decrease of miR‐132‐3p and of three family‐related miRNAs encoded by the same miRNA cluster on chromosome 17. Deregulation of miR‐132‐3p in AD brain appears to occur mainly in neurons displaying Tau hyper‐phosphorylation. We provide evidence that miR‐132‐3p may contribute to disease progression through aberrant regulation of mRNA targets in the Tau network. The transcription factor (TF) FOXO1a appears to be a key target of miR‐132‐3p in this pathway.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201201974

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Multiple miRNAs are dysregulated in the affected regions of AD brains.

    “Recent miRNA profiling studies showed that multiple miRNAs are dysregulated in the affected regions of AD brains (Lau et al. 2013, Hebert et al. 2008, Wang et al. 2011, Delay et al. 2012, Cogswell et al. 2008, Lukiw 2007).”
  • miR-186 is up-regulated in the grey matter of the prefrontal cortex in AD brains.

    “On the other hand, another study reported that miR-186 is up-regulated in the grey matter of the prefrontal cortex in AD brains (Lau et al. 2013).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. Alkalay A Rabinovici GD Zimmerman G Agarwal N Kaufer D Miller BL Jagust WJ Soreq H Plasma acetylcholinesterase activity correlates with intracerebral beta-amyloid load Curr Alzheimer Res 2013 10 48 56 23157337 PMC3768143
  2. Alon S Mor E Vigneault F Church GM Locatelli F Galeano F Gallo A Shomron N Eisenberg E Systematic identification of edited microRNAs in the human brain Genome Res 2012 22 1533 1540 22499667 PMC3409266
  3. Anders S Huber W Differential expression analysis for sequence count data Genome Biol 2010 11 R106 20979621 PMC3218662
  4. Berson A Barbash S Shaltiel G Goll Y Hanin G Greenberg DS Ketzef M Becker AJ Friedman A Soreq H Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice EMBO Mol Med 2012 4 730 742 22628224 PMC3494073
  5. Berson A Knobloch M Hanan M Diamant S Sharoni M Schuppli D Geyer BC Ravid R Mor TS Nitsch RM Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology Brain 2008 131 109 119 18056160
  6. Blalock EM Geddes JW Chen KC Porter NM Markesbery WR Landfield PW Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses Proc Natl Acad Sci USA 2004 101 2173 2178 14769913 PMC357071
  7. Bossers K Wirz KT Meerhoff GF Essing AH van Dongen JW Houba P Kruse CG Verhaagen J Swaab DF Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease Brain 2010 133 3699 3723 20889584
  8. Bronner IF Bochdanovits Z Rizzu P Kamphorst W Ravid R van Swieten JC Heutink P Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways PLoS One 2009 4 e6826 19714246 PMC2729393
  9. Cambronne XA Shen R Auer PL Goodman RH Capturing microRNA targets using an RNA-induced silencing complex (RISC)-trap approach Proc Natl Acad Sci USA 2012 109 20473 20478 23184980 PMC3528561
  10. Chen-Plotkin AS Unger TL Gallagher MD Bill E Kwong LK Volpicelli-Daley L Busch JI Akle S Grossman M Van Deerlin V TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways J Neurosci 2012 32 11213 11227 22895706 PMC3446826
  11. Chiang HR Schoenfeld LW Ruby JG Auyeung VC Spies N Baek D Johnston WK Russ C Luo S Babiarz JE Mammalian microRNAs: Experimental evaluation of novel and previously annotated genes Genes Dev 2010 24 992 1009 20413612 PMC2867214
  12. Edbauer D Neilson JR Foster KA Wang CF Seeburg DP Batterton MN Tada T Dolan BM Sharp PA Sheng M Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132 Neuron 2010 65 373 384 20159450 PMC5018398
  13. Gomez Ravetti M Rosso OA Berretta R Moscato P Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease PLoS One 2010 5 e10153 20405009 PMC2854141
  14. Hebert SS Horre K Nicolai L Papadopoulou AS Mandemakers W Silahtaroglu AN Kauppinen S Delacourte A De Strooper B Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression Proc Natl Acad Sci USA 2008 105 6415 66420 18434550 PMC2359789
  15. Hebert SS Wang WX Zhu Q Nelson PT A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls J Alzheimers Dis 2013 35 335 348 23403535 PMC3753694
  16. Heinz S Benner C Spann N Bertolino E Lin YC Laslo P Cheng JX Murre C Singh H Glass CK Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities Mol Cell 2010 38 576 589 20513432 PMC2898526
  17. Herrmann C Van de Sande B Potier D Aerts S i-cisTarget: An integrative genomics method for the prediction of regulatory features and cis-regulatory modules Nucleic Acids Res 2012 40 e114 22718975 PMC3424583
  18. Hoekman MF Jacobs FM Smidt MP Burbach JP Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain Gene Expr Patterns 2006 6 134 140 16326148
  19. Johnson R Zuccato C Belyaev ND Guest DJ Cattaneo E Buckley NJ A microRNA-based gene dysregulation pathway in Huntington's disease Neurobiol Dis 2008 29 438 445 18082412
  20. Junker A Krumbholz M Eisele S Mohan H Augstein F Bittner R Lassmann H Wekerle H Hohlfeld R Meinl E MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47 Brain 2009 132 3342 3352 19952055
  21. Lau P de Strooper B Dysregulated microRNAs in neurodegenerative disorders Semin Cell Dev Biol 2010 21 768 773 20080199
  22. Lau P Verrier JD Nielsen JA Johnson KR Notterpek L Hudson LD Identification of dynamically regulated microRNA and mRNA networks in developing oligodendrocytes J Neurosci 2008 28 11720 11730 18987208 PMC2646797
  23. Liang D Han G Feng X Sun J Duan Y Lei H Concerted perturbation observed in a hub network in Alzheimer's disease PLoS One 2012 7 e40498 22815752 PMC3398025
  24. Luikart BW Bensen AL Washburn EK Perederiy JV Su KG Li Y Kernie SG Parada LF Westbrook GL miR-132 mediates the integration of newborn neurons into the adult dentate gyrus PLoS One 2011 6 e19077 21611182 PMC3096628
  25. Magill ST Cambronne XA Luikart BW Lioy DT Leighton BH Westbrook GL Mandel G Goodman RH microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus Proc Natl Acad Sci USA 2010 107 20382 20387 21059906 PMC2996687
  26. Mellios N Sugihara H Castro J Banerjee A Le C Kumar A Crawford B Strathmann J Tropea D Levine SS miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity Nat Neurosci 2011 14 1240 1242 21892155 PMC3183341
  27. Miller BH Zeier Z Xi L Lanz TA Deng S Strathmann J Willoughby D Kenny PJ Elsworth JD Lawrence MS MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function Proc Natl Acad Sci USA 2012 109 3125 3130 22315408 PMC3286960
  28. Nunez-Iglesias J Liu CC Morgan TE Finch CE Zhou XJ Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation PLoS One 2010 5 e8898 20126538 PMC2813862
  29. Poorkaj P Kas A D'Souza I Zhou Y Pham Q Stone M Olson MV Schellenberg GD A genomic sequence analysis of the mouse and human microtubule-associated protein tau Mamm Genome 2001 12 700 7712 11641718
  30. Pritchard CC Cheng HH Tewari M MicroRNA profiling: Approaches and considerations Nat Rev Genet 2012 13 358 369 22510765 PMC4517822
  31. Remenyi J Hunter CJ Cole C Ando H Impey S Monk CE Martin KJ Barton GJ Hutvagner G Arthur JS Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins Biochem J 2010 428 281 291 20307261
  32. Salta E De Strooper B Non-coding RNAs with essential roles in neurodegenerative disorders Lancet Neurol 2012 11 189 200 22265214
  33. Schonrock N Ke YD Humphreys D Staufenbiel M Ittner LM Preiss T Gotz J Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta PLoS One 2010 5 e11070 20552018 PMC2884018
  34. Shaked I Meerson A Wolf Y Avni R Greenberg D Gilboa-Geffen A Soreq H MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase Immunity 2009 31 965 973 20005135
  35. Shaltiel G Hanan M Wolf Y Barbash S Kovalev E Shoham S Soreq H Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target Brain Struct Funct 2013 218 59 72 22246100 PMC3535403
  36. Shan L Bossers K Unmehopa U Bao AM Swaab DF Alterations in the histaminergic system in Alzheimer's disease: A postmortem study Neurobiol Aging 2012 33 2585 2598 22284987
  37. Smith PY Delay C Girard J Papon MA Planel E Sergeant N Buee L Hebert SS MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy Hum Mol Genet 2011 20 4016 4024 21807765
  38. Tanzi RE The Genetics of Alzheimer Disease Cold Spring Harb Perspect Med 2012 2 a006296 23028126 PMC3475404
  39. Tognini P Putignano E Coatti A Pizzorusso T Experience-dependent expression of miR-132 regulates ocular dominance plasticity Nat Neurosci 2011 14 1237 1239 21892154 PMC3183093
  40. Vo N Klein ME Varlamova O Keller DM Yamamoto T Goodman RH Impey S A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis Proc Natl Acad Sci USA 2005 102 16426 16431 16260724 PMC1283476
  41. Waggott D Chu K Yin S Wouters BG Liu FF Boutros PC NanoStringNorm: An extensible R package for the pre-processing of NanoString mRNA and miRNA data Bioinformatics 2012 28 1546 1548 22513995 PMC3356845
  42. Wanet A Tacheny A Arnould T Renard P miR-212/132 expression and functions: Within and beyond the neuronal compartment Nucleic Acids Res 2012 PMC3367188 22362752
  43. Wang WX Huang Q Hu Y Stromberg AJ Nelson PT Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: White matter versus gray matter Acta Neuropathol 2011 121 193 205 20936480 PMC3073518
  44. Wang WX Rajeev BW Stromberg AJ Ren N Tang G Huang Q Rigoutsos I Nelson PT The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1 J Neurosci 2008 28 1213 1223 18234899 PMC2837363
  45. Wong HK Veremeyko T Patel N Lemere CA Walsh DM Esau C Vanderburg C Krichevsky AM De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease Hum Mol Genet 2013 22 3077 3092 23585551 PMC13387022
  46. Wyman SK Knouf EC Parkin RK Fritz BR Lin DW Dennis LM Krouse MA Webster PJ Tewari M Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity Genome Res 2011 21 1450 1461 21813625 PMC3166830

Cited by

Sorted by citations

Authors
Lau, P., Bossers, K., Janky, R., Salta, E., Frigerio, C. S., Barbash, S., Rothman, R., Sierksma, A. S. R., Thathiah, A., Greenberg, D., Papadopoulou, A. S., Achsel, T., Ayoubi, T., Soreq, H., Verhaagen, J., Swaab, D. F., Aerts, S., & De Strooper, B.
Affiliations
  • Universitair Ziekenhuis Leuven (BE)
  • Netherlands Institute for Neuroscience (NL)
  • KU Leuven (BE)
  • Hebrew University of Jerusalem (IL)
Venue
EMBO Molecular Medicine
Published
2013-09-09
Volume
5
Issue
10
Pages
1613-1634
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2096128947
Cited by
474
References
6
Citations by year
2026: 14 · 2025: 24 · 2024: 30 · 2023: 27 · 2022: 43 · 2021: 50 · 2020: 47 · 2019: 40 · 2018: 44 · 2017: 43 · 2016: 40 · 2015: 34 · 2014: 33 · 2013: 5
FWCI
13.14
Type
journal article
Language
en
Open access
Locations
  • EMBO Molecular Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
  • Lirias (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (submittedVersion, other-oa)
Funders
  • Teva Pharmaceutical Industries
  • University of Pennsylvania
  • Multiple Sclerosis Society
  • Belgian Federal Science Policy Office
  • Fonds Wetenschappelijk Onderzoek
  • Top Institute Pharma (T5-207)
  • Vlaamse regering
  • Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, microRNA dysregulation, miR-132-3p, hippocampus, prefrontal cortex, Braak stages, disease progression, tau hyperphosphorylation, FOXO1, microRNA target regulation
MeSH terms
Alzheimer Disease, Brain, Chromosomes, Human, Pair 17, Hippocampus, Humans, Neurons, Phosphorylation, ROC Curve, Severity of Illness Index, Cohort Studies, Down-Regulation, Cluster Analysis, tau Proteins, Disease Progression, Area Under Curve, Gene Expression Profiling, MicroRNAs, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review